OPEN END TURBO OPTIONSSCHEIN SHORT - BRISTOL-MYERS SQUIBB | Market Closed - BOERSE MUENCHEN 02:25:49 2024-07-12 pm EDT | ||
| 0.945 EUR | +3.05% |
|
| Current month | +5.35% | ||
| 1 month | +16.24% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-07-12 | 0.945 | +3.05% |
| 24-07-11 | 0.917 | -1.82% |
| 24-07-10 | 0.934 | -3.51% |
| 24-07-09 | 0.968 | -5.47% |
| 24-07-08 | 1.024 | -3.40% |
Real-time BOERSE MUENCHEN
Last update July 12, 2024 at 02:25 pm EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | Goldman Sachs |
| WKN | GG623B |
| ISIN | DE000GG623B4 |
| Date issued | 2024-04-11 |
| Strike | 50.98 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.12 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.065 € |
|---|---|
| Lowest since issue | 0.209 € |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
40.46
USD
Average target price
52.74
USD
Spread / Average Target
+30.35%
- Stock Market
- Certificates
- Certificat
